Successful perioperative management using prothrombin complex concentrates in patients with severe congenital protein...

Area of Science:

• Hematology
• Thrombosis and Hemostasis

Background:

• Severe congenital protein C deficiency poses challenges for perioperative management.
• Anticoagulant therapy (e.g., warfarin) requires discontinuation during surgery, creating a management gap.
• Established protocols for managing these patients perioperatively are lacking.

Purpose of the Study:

• To evaluate the efficacy and safety of using prothrombin complex concentrates (PCC) for perioperative management in severe congenital protein C deficiency.
• To establish a potential management strategy for patients undergoing surgery.

Main Methods:

• A management approach involving intermittent administration of prothrombin complex concentrates (PCC), including inactive protein C (PPSB-HT), was adopted.
• Three patients with severe congenital protein C deficiency underwent six surgical procedures under this management strategy.
• Monitoring of protein C activity and other coagulation factors (e.g., factor IX) was performed.

Main Results:

• The PCC treatment strategy allowed for successful perioperative management of the patients.
• Coagulation factor levels were monitored throughout the perioperative period.
• No adverse events related to the management strategy were explicitly mentioned, implying successful outcomes.

Conclusions:

• Prothrombin complex concentrates (PCC) provide a feasible and effective method for perioperative management of severe congenital protein C deficiency.
• This approach facilitates the safe surgical treatment of patients with this rare bleeding disorder.
• Further research may validate this strategy for broader clinical application.